Publications

    Guidelines:

    • National Institute for Health and Care Excellence (NICE) Interventional Procedures Guidance (IPG475):  Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia. January 2014
      https://www.nice.org.uk/guidance/ipg475


    Meta-Analyses:

    • Roehrborn C, Prostatic urethral lift: a unique minimally invasive surgical treatment of male lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Clin N Am 2016
      View Abstract

    • Shore N, A Review of the Prostatic Urethral Lift for Lower Urinary Tract Symptoms: Symptom Relief, Flow Improvement, and Preservation of Sexual Function in Men With Benign Prostatic Hyperplasia. Curr Bladder Dysfunct Rep 2014.
      View Full Article
    • Perera M, et al., Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol 2015 article and addendum
      View Abstract

     

    Clinical Studies:

    • Eure G, Gange S, Walter P, Khan A, Chabert C, Mueller T, Cozzi P, Patel M, Freedman S, Chin P, Ochs S, Hirsh A, Trotter M, and Grier D. Real-World Evidence of Prostatic Urethral Lift Confirms Pivotal Clinical Study Results: 2-Year Outcomes of a Retrospective Multicenter Study. J of Endourology 2019.
      View Full Article
    • Roehrborn CG, Rukstalis DB, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rashid P. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol 2017; 24(3); 8802-8813.
      View Full Article
    • Gratzke C, Barber N, Speakman M, Berges R, Wetterauer U, Greene D, Sievert KD, Chapple C, Sonksen J. Prostatic urethral lift (PUL) vs transurethral resection of the prostate (TURP): 2 year results of the BPH6 prospective, multi-center, randomised study. BJU Int. 2017; 119: 767-775.
      View Full Article
    • Shah BB, Tayon K, Madiraju SG, Carrion RE, Perito P. Prostatic urethral lift: does size matter? J Endourol 2018; DOI: 10.1089/end.2017.0855.
    • Keehn A, Fram E, Garg M, Maria P. UroLift in place of fiducial markers for patients with benign prostatic hyperplasia undergoing external beam radiation therapy. Urology 2017; 104: 230-234.
    • Walsh L. State of the art: advanced techniques for prostatic urethral lift for the relief of prostate obstruction under local anesthesia. Can J Urol 2017; 24(3); 8859-8864.
      View Full Article
    • Schoenthaler M, Sievert KD, Schoeb DS, Miernik A, Kunit T, Hein S, Herrmann TRW, Wilhelm K. Combined prostatic urethral lift and remodeling of the prostate and bladder neck: a modified transurethral approach in the treatment of lower urinary tract obstruction. W J Urol 2018;
      View Abstract
    • Bardoli AD, Taylor WS, Mahmalji W. Can the UroLift prostatic implant device treat the symptoms of benign prostatic hypertrophy, avoid sexual dysfunction and reduce hospital TURP waiting times? A single centre, single surgeon experience and review of the literature. Aging Male 2017; 20(3): 192-197.
    • Rukstalis D, Rashid P, Bogache W, Tutrone R, Barkin J, Chin P, Woo H, Cantwell A, Cowan B, Bolton D. Two year durability after crossover to the prostatic urethral lift from randomized, blinded sham. BJUI 2016; doi: 10.1111/bju.13666.
      View Full Article
    • Roehrborn CG. Prostatic urethral lift: a unique minimally invasive surgical treatment of male lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Clin N Am 2016; 43: 357-369.
      View Abstract 
    • Roehrborn CG, Rukstalis DB, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rashid P. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol 2015; 22(3); 7772-7782.
      View Full Article
    • Sønksen J, Barber NJ, Speakman M et al. Prospective, Randomized, Multinational Study of Prostatic Urethral Lift Versus Transurethral Resection of the Prostate: 12-month Results from the BPH6 Study. Eur Urol 2015; 68; 643-652.
      View Full Article
    • Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Brown BT, McVary KT, Te AE, Gholami SS, Rashid P, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rukstalis DB. Durability of the prostatic urethral lift: two year results of the L.I.F.T. Study. Urology Practice 2015 (2); 1-7.
      View Full Article
    • Shore N, Freedman S, Gange S, Moseley W, Heron S, Tutrone R, Brown T, Barkin J. Prospective multi-center study elucidating patient experience after prostatic urethral lift. Can J Urology 2014; 21(1): 7094-7101.
      View Full Article
    • Cantwell AL, Bogache WK, Richardson SF, Tutrone RF, Barkin J, Fagelson JE, Chin PT, Woo HH. Multi-Center prospective crossover study of the prostatic urethral lift for the treatment of LUTS secondary to BPH. BJUI 2013; 113: 615-622.
      View Abstract 
    • McVary KT, Gange SN, Shore ND, Bolton DM, Cowan BE, Brown BT, Te AE, Chin PT, Rukstalis DB, Roehrborn CG. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of the prostatic urethral lift. J Sex Med 2014; 11: 279-287
      View Abstract 
    • Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Brown BT, McVary KT, Te AE, Gholami SS, Rashid P, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rukstalis DB. Multi-Center randomized controlled blinded study of the prostatic urethral lift for the treatment of LUTS associated with prostate enlargement due to BPH: the L.I.F.T. study. J Urol 2013; 190: 2162-2167.
      View Abstract 
    • McNicholas TA, Woo HH, Chin PT, Bolton D, Fernandez-Arjona M, Sievert, KD, Schoenthaler M, Wetterauer U, Vrijhof EJEJ, Gange S, Montorsi F: Minimally invasive Prostatic Urethral Lift: surgical technique and multinational study. Eur Urol 2013; 64: 292-299.
      View Abstract 
    • Chin PT, Bolton DM, Rashid JG, Thavaseelan J, Yu RJ, Roehrborn CG, Woo HH. Prostatic Urethral Lift:  Two-year results after treatment for lower urinary symptoms secondary to benign prostatic hyperplasia.  Urology 2012; 79: 5-11.
      View Abstract 
    • Barkin J Giddens J, Ineze P, Casey R, Richardson S, Gange S. UroLift system for the relief of prostate obstruction under local anesthesia.  Can J Urology 2012; 19: 6217-6222.
      View Abstract 
    • Woo HH, Bolton DM, Laborde E, Jack G, Chin PT, Rashid P, Thavaseelan J, McVary KT. Preservation of sexual function with the prostatic urethral lift:  a novel treatment for lower urinary tract symptoms secondary to benign prostatic hypertrophy.  J Sex Med 2012; 9: 568-575.
      View Abstract 
    • Woo HH, Chin PT, McNicholas TA, Harscharan G, Plante MK, Bruskewitz RC, Roehrborn CG. Safety and feasibility of the prostatic urethral lift: a novel minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hypertrophy (BPH).  BJU Int 2011; 108: 82-88.
      View Abstract 
    • Rukstalis D, Grier D, Stroup S, Tutrone R, deSouza E, Freedman S, David R, Kaminetsky J, Eure G. Prostatic urethral lift (PUL) for obstructive median lobes: 12 month results of the MedLift study. Prostate Can Prost Dis 2018;
      View Abstract 
    • Sievert KD, Schonthaler M, Berges R, Toomey P, Drager D, Herlemann A, Miller F, Wetterauer U, Volkmer B, Gratzke C, Amend B. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years. World J Urol;
      View Full Article
    • Biswal NC, Swann B, McKenna MG, Singh R. UroLift as a surrogate for fiducial markers in IGRT planning of prostate cancer in BPH patients. Practical Rad Onc 2018; 8: e231-e233.
    • Bozkurt A, Karabakan M, Keskin E, Hirik E, Balci MBC, Nuhoglu B. Prostatic urethral lift: a new minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Int 2016; 96: 202-206.
    • Beurrier S, Peyromaure M, Belas O, Delongchamps NB. La pose d’implants intra-prostatiques UroLift est-elle une alternative chez les patients ayant une hyperplasie benigne de la prostate? Resultats initiaux et facteurs predictifs d’echec. Progres en Urologie 2015; 25; 523-529.
    • Akin Y, Bozkurt A, Oguz Keles M, Gulmez H, Sahin M, Nuhoglu B. Benign prostat hiperplazisi nin yeni minimal invasive tedavi secenegi: prostat icerisine UroLift uygulamasi, erken donem sonuclari ile Turkiye den ilk vaka serisi. JAREM 2013; 3; 74-78.
    • Garrido Abad P, Coloma del Peso A, Sinues Ojas B, Fernandez Arjona F. UroLift, un Nuevo tratmiento minimament invasive para los sintomas de tracto urinario inferior secudarios a HBP. Resutados preliminaries. Urologia Neurologica y Urodinamico: Arch. Esp. Urol. 2013; 66(6): 584-591.
      View Abstract 
    • Delongchamps NB, Conquy S, Defontaines J, Zerbib M, Peyromaure M. Pose d’implants UroLift intra-prostatiques pour hyperplasie benigne de la prostate: resultats preliminaires des quatre premiers cas realizes en France. Progres en urologie 2012; 22: 590-597.
      View Abstract 


    Reviews:

    • Rieken M, Antunes-Lopes T, Geavlete B, Marcelissen T. What is new with sexual side effects after transurethral male lower urinary tract symptom surgery? Eur Urol 2018;
      View Abstract 
    • Giona S, Ganguly I, Muir G. Urologists’ attitudes to sexual complications of LUTS/BPH treatments. W J Urol 2018;
      View Abstract 
    • Magistro G, Weinhold P, Stief CG, Gratzke C. The new kids on the block: prostatic urethral lift (UroLift) and convective water vapor energy ablation (Rezum). Curr Opin Urol 2018; DOI:10.1097/MOU.0000000000000502.
    • Gupta NK, Gange SN, McVary KT. New and emerging technologies in treatment of lower urinary tract symptoms from benign prostatic hyperplasia. Sex Med Rev 2018: 1-8.
    • Magistro G, Stief CG, Woo HH. Mini review: what’s new with UroLift? Eur Urol 2018;
      View Abstract 
    • Chung ASJ, Woo HH. Update on minimally invasive surgery and benign prostatic hyperplasia. Asian J Urol 2018; 5: 22-27.
      View Full Article
    • Magistro G, Chapple CR, Elhilali M, Gilling P, McVary KT, Roehrborn CG, Stief CG, Woo HH, Gratzke C. Emerging minimally invasive treatment options for male lower urinary tract symptoms. Eur Urol 2017; 72:986-997.
    • Chin P, Robertson P. Medium-term efficacy of the prostatic urethral lift. Transl Androl Urol 2017; 1-11;
      View Full Article
    • Kirby R. Surgical treatment of LUTS secondary to BPH. Urology News 2017; 21(3):1-5.
      View Full Article
    • Albisinni S, Aoun F, Roumeguere T, Porpiglia F, Tubaro A, De Nunzio C. New treatment strategies for benign prostatic hyperplasia in the frail elderly population: a systematic review. Minerva Urol Nefrol 2017; 69(2): 119-132.
    • Pushkaran A, Stainer V, Muir G, Shergill IS. UroLift – minimally invasive surgical BPH management. Expert Review 2017; 14(3): 223-228.
    • Roehrborn CG. Prostatic urethral lift: a unique minimally invasive surgical treatment of male lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Clin N Am 2016; 43: 357-369.
      View Abstract 
    • McNicholas TA. Benign prostatic hyperplasia and new treatment options –a critical appraisal of the UroLift system. Medical Devices: Evidence and Research 2016; 9; 115-123.
      View Full Article
    • Chung A, Woo HH. Preservation of sexual function when relieving benign prostatic obstruction surgically: can a trade-off be considered? Curr Opin Urol 2016; 26(1): 42-48.
    • Jones P, Rajkumar GN, Ral BP, Aboumarzouk OM, Cleaveland P, Srirangam SJ, Somani BK. Medium-term outcomes of UroLift (minimum 12 months follow-up): Evidence from a systematic review. Urology 2016; 97: 20-24.
    • Jones P, Rai BP, Aboumarzouk OM, Somani BK. Prostatic urethral lift vs prostate arterial embolization: novel nonablative strategies in the management of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 2016; 87: 11-17.
    • Marra G, Sturch P, Oderda M, Tabatabaei S, Muir G, Gontero P. Systematic review of the lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men’s ejaculatory function: Time for a bespoke approach? Int J Urol 2016; 23(1): 22-35.
      View Full Article
    • Tsui JF, Dixon CM. UroLift: a new face of minimally invasive surgical technique for benign prostatic hyperplasia? Curr Urol Rep 2016; 17(63):1-5. Magistro G, Stief CG, Gratzke C. New Intraprostatic injectables and prostatic urethral lift for male LUTS. Nature Rev Urol 2015; 12: 461-471.
    • Rukstalis DB. Prostatic urethral lift: a novel approach for managing symptomatic BPH in the aging man. Can J Urol 2015; 22:67-74.
      View Full Article
    • Sturch P, Woo HH, McNicholas TA, Muir G. Ejaculatory dysfunction after treatment for lower urinary tract symptoms: retrograde ejaculation or retrograde thinking? BJUI 2015; 115: 186-187.
      View Full Article
    • Garcia C, Chin P, Rashid P, Woo HH. Prostatic urethral lift: a minimally invasive treatment for benign prostatic hyperplasia. Prostate Int 2015; 3: 1-5.
      View Full Article
    • Aoun F, Marcelis Q, Roumeguere T. Minimally invasive devices for treating lower urinary tract symptoms in benign prostate hyperplasia: technology update. Res and Rep in Urol 2015; 7: 125-136.
      View Full Article
    • Chughtai B, Kaplan S. Surgical treatment of benign prostatic hyperplasia – lift or laser? Urology Practice 2014 (1); 45-48.
      View Full Article
    • Becher EF, McVary KT. Surgical procedures for BPH/LUTS: Impact on male sexual health. Sex Med Rev 2014; 2: 47-55.
      View Full Article
    • Clarke JL. Optimizing population health and economic outcomes: innovative treatment for benign prostatic hyperplasia (BPH). Pop Health Mgt 2013; 16(2); S1-S13.
      View Full Article
    • Payton S. Promising future for the prostatic urethral lift. Nature Rev. Urol 10, 677 (2013); published online 26 November 2013; doi:10.1038/nrurol.2013.267.
      View Full Article
    • Larcher A, Broglia L, Lughezzani G, Mistretta F, Abrate A, Lista G, Fossati N, Sangalli M, Kuefner D, Cestari A, Buffi N, Lazzeri M, Guazzoni G, Montorsi F. Urethral lift for benign prostatic hyperplasia: a comprehensive review of the literature. Curr Urol Rep 21 JUN 2013;DOI:10.1007/s11934-013-0348-3.Bell J, Laborde E: Update on sexual impact of treatment for Benign Prostatic Hyperplasia. Curr Urol Rep 12 October 2012; http://DOI 10.1007/s11934-012-0278-5.
      View Full Article
    • Batura D, Sahibzada I. TURP in the era of UroLift. Int Urol Nephrol. 2018;50(5):877-878. doi:10.1007/s11255-018-1833-x.
    • Magistro G, Stief C, Gratzke C. Prostatic Urethral Lift Versus Transurethral Resection of the Prostate (TURP). Curr Urol Rep. 2017;18(10). doi:10.1007/s11934-017-0725-4.
    • Lebdai S, Chevrot A, Doizi S et al. Do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatment. World J Urol. 2018;37(2):299-308. doi:10.1007/s00345-018-2368-6.
    • Patel R, Bariol S. National trends in surgical therapy for benign prostatic hyperplasia in Australia. ANZ J Surg. 2019. doi:10.1111/ans.15016.
    • Gilling P. Does the UroLift® device change things?. BJU Int. 2017;119:6-6. doi:10.1111/bju.13773.
      View Full Article
    • Kaplan S. Re: Prospective, Randomized, Multinational Study of Prostatic Urethral Lift versus Transurethral Resection of the Prostate: 12-Month Results from the BPH6 Study. Journal of Urology. 2017;197(2):484-484. doi:10.1016/j.juro.2016.11.045.
    • Jones P, Rai B, Aboumarzouk O, Somani B. UroLift: a new minimally-invasive treatment for benign prostatic hyperplasia. Ther Adv Urol. 2016;8(6):372-376. Doi:10.1177/1756287216671497.
      View Full Article
    • Jones P, Rai B, Aboumarzouk O, Somani B. UroLift: a new chapter in benign prostate hyperplasia (BPH) therapy. Ann Transl Med. 2016;4(6):116-116. doi:10.21037/atm.2016.01.29.
      View Full Article
    • Peyton C, Badlani G. The management of prostatic obstruction with urethral stents. Can J Urol. 2019. PMID: 26497347.
    • Gilling P. Does the Prostatic Urethral Lift Change the BPH Treatment Paradigm?. Can J Urol. 2015. PMID: 26267020.
      View Full Article
    • Bultitude M, Le Roux P. Re: Jens Sønksen, Neil J. Barber, Mark J. Speakman, et al. Prospective, Randomized, Multinational Study of Prostatic Urethral Lift Versus Transurethral Resection of the Prostate: 12-month Results from the BPH6 Study. Eur Urol 2015;68:643–52. Eur Urol. 2016;69(3):e37-e38. doi:10.1016/j.eururo.2015.07.015
    • Roberts M, Perera M, Doi S, Bolton D. Re: Marlon Perera, Matthew J. Roberts, Suhail A.R. Doi, Damien Bolton. Prostatic Urethral Lift Improves Urinary Symptoms and Flow While Preserving Sexual Function for Men with Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis. Eur Urol 2015;67:704–13. Eur Urol. 2015;68(3):e53-e54. doi:10.1016/j.eururo.2015.05.035
    • Pham H, Pranav S. Emerging newly-approved treatments for lower urinary tract symptoms secondary to benign prostatic hypertrophy. Can J Urol. 2018. PMID: 29679999.
      View Full Article
    • Ray A, Morgan H, Wilkes A, Carter K, Carolan-Rees G. The Urolift System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance. Appl Health Econ Health Policy. 2016;14(5):515-526. Doi:10.1007/s40258-015-0218-x.
      View Full Article
    • Kaplan S. Re: Treatment of LUTS Secondary to BPH while Preserving Sexual Function: Randomized Controlled Study of Prostatic Urethral Lift. Journal of Urology. 2015;194(1):168-169. doi:10.1016/j.juro.2015.04.044.
    • Chughtai B, Te A, Kaplan S, Lee R. The Prostatic Urethral Lift Procedure: Enough Bang for the Buck?. Eur Urol. 2015;68(4):653-654. Doi:10.1016/j.eururo.2015.05.006.
    • Stone L. BPH6 results will lift the spirits of men with LUTS secondary to BOO. Nature Reviews Urology. 2015;12(6):299-299. doi:10.1038/nrurol.2015.115.
    • Kaplan S. The Prostate Urethral Lift: Will It Be Uplifting or Downgraded as a Treatment Strategy for Benign Prostatic Hyperplasia?. Eur Urol. 2015;67(4):714-715. doi:10.1016/j.eururo.2014.12.013.
    • Gupta S, Singh V, Goel A. Re: the prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. C. G. Roehrborn, S. N. Gange, N. D. Shore, J. L. Giddens, D. M. Bolton, B. E. Cowan, B. T. Brown, K. T. McVary, A. E. Te, S. S. Gholami, P. Rashid, W. G. Moseley, P. T. Chin, W. T. Dowling, S. J. Freedman, P. F. Incze, K. S. Coffield, F. D. Borges and D. B. Rukstalis J Urol 2013;190:2161-2167. J Urol. 2014. PMID: 25405255.
    • Gupta S. L.I.F.T. study: Prostatic urethral lift for the treatment of LUTS associated with BPH. Indian J Urol. 2014. PMID: 24744530.
    • Thiruchelvam N. Surgical therapy for benign prostatic hypertrophy/bladder outflow obstruction. Indian J of Urol. 2014;30(2):202. Doi:10.4103/0970-1591.126907.
    • Mavuduru R, Devana S, Nayak B, Gupta S, Singh V, Goel A. Re: The Prostatic Urethral Lift for the Treatment of Lower Urinary Tract Symptoms Associated with Prostate Enlargement Due to Benign Prostatic Hyperplasia: The L.I.F.T. Study. Journal of Urology. 2014;191(6):1934-1936. doi:10.1016/j.juro.2013.10.150.
    • Ulchaker J, Martinson M. Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. ClinicoEconomics and Outcomes Research. 2017;Volume 10:29-43. doi:10.2147/ceor.s148195.
      View Full Article
    • Westhofen T, Magistro G, Stief C, Gratzke C. Das UroLift® System in der Behandlung des benignen Prostata-Syndroms (BPS). Aktuelle Urol. 2018;49(06):515-518. doi:10.1055/a-0759-9185.
    • Magistro G, Stief C, Gratzke C. Neue minimal-invasive Therapie des benignen Prostatasyndroms. Urologe. 2019;58(3):254-262. doi:10.1007/s00120-019-0876-7.
    • Magistro G, Stief C, Gratzke C. Minimal-invasive Therapie des benignen Prostatasyndroms. Urologe. 2016;55(11):1419-1432. doi:10.1007/s00120-016-0249-4.
    • Liang J, Lu Y. Prostatic urethral lift: A novel minimally invasive treatment for benign prostatic hyperplasia. Zhonghua Nan Ke Xue. 2016. PMID: 29019232
    • Liang J, Lu Y. Minimally invasive techniques in the treatment of benign prostatic hyperplasia: An update. Zhonghua Nan Ke Xue. 2016. PMID: 27416660.
    • Sánchez-Gómez L, Polo-deSantos M, Gómez-Sancha F, Luengo-Matos S. Efectividad y seguridad del evisio Urolift® para el tratamiento de los síntomas de la evision ia benigna de próstata: evision sistemática. Actas Urológicas Españolas. 2015;39(5):311-319. Doi:10.1016/j.acuro.2014.05.010.
    • Arenas da Silva LF, Schonthaler M, Cruz F, Gratzke C, Zumbe J, Stenzl A, Amend B, Sievert KD. Neue behandlungskonzepte von symptomen des unteren harntraktes beim mann. Urologue 2012; 51: 1697-1702.
      View Full Article

     

    Case Studies/Reports:

    • Bardoli, Antonio Devanti, et al. “Is There a Minimally Invasive Day Case Operation to Treat LUTS Secondary to BPH and Avoid Sexual Dysfunction? UroLift A Case Report.” Journal of Men's Health, vol. 14, no. 1, 1 Jan. 2018, pp. e11–e13., doi:10.22374/1875-6859.14.1.3.
      View Full Article

    • Iqbal M, Jones R, Hughes S, Shergill I. Low power HOLEP after failed urolift: A case report using 50 Watt laser. Urol Case Rep. 2018;16:114-115. doi:10.1016/j.eucr.2017.11.029.
      View Full Article
    • Tapping C, Little M, Boardman P. Successful Prostatic Artery Embolization following UroLift Device Failure. Journal of Vascular and Interventional Radiology. 2017;28(9):1275-1276. doi:10.1016/j.jvir.2017.02.028.
    • Kuo H, Liao C. Current consensus and controversy on the treatment of male lower urinary tract symptoms/benign prostatic hyperplasia. Tzu Chi Medical Journal. 2017;29(1):1. doi:10.4103/tcmj.tcmj_2_17.
      View Full Article

    The UroLift System is a Medical Device, class: IIb. Notified Body : NSAI- CE 0050. Manufacturer: NeoTract Inc. Pleasanton -USA. . Please refer very carefully to the instructions for use for recommendations. Check the integrity of the packaging before use. Product reimbursed by health insurance organizations in certain situations: consult the terms and conditions on http://www.ameli.fr

    4155 Hopyard Road

    Pleasanton, CA 94588

    Phone: (925) 401-0700

    Fax: (925) 401-0699

    © 2025 Teleflex Incorporated. All rights reserved. MAC01814-04 Rev A    |    Terms of Use   |    Privacy Policy   |   Patient Safety


    MA00914-01 Rev C